One of our most effective tools, Tirzepatide, has shown remarkable promise in supporting sustainable weight loss while improving overall well-being
A 2025 trial comparing methylene blue and vasopressin as adjunctive medications found that vasopressin is more effective than methylene blue beyond the initial 6-hour window in reducing the need for norepinephrine, improving lactate levels, and enhancing organ function
As background to the study, the investigators noted that there have been no previous direct comparisons between GLP- 1 RAs and metformin for preventing dementia in patients with type 2 diabetes
Gastrointestinal side effects, including constipation, are a primary reason some patients may need to delay dose escalation or temporarily reduce their dose
These tools should be used only with information from a prescription label, licensed provider, or dispensing pharmacy